Inventor
Ling Wang
Inventor
Fremont, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes13%
C07DHeterocyclic compounds10%
C07KPeptides8%
C12NMicroorganisms or enzymes6%
Y02ATechnologies for adaptation to climate change6%
C07BGeneral methods of organic chemistry5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
C40BCombinatorial chemistry3%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
PatentTitleYear
10,966,442Refrigerator202110,890,369Refrigerating and freezing device202110,538,565Method of treating diseases with recombinant human interferon-like proteins202010,421,763Compositions of protein receptor tyrosine kinase inhibitors201910,301,271Crystalline forms of tyrosine kinase inhibitors and their salts201910,124,002Crystalline forms of tyrosine kinase inhibitors and their salts201810,106,550Aza-phenalene-3-ketone derivative, preparation method thereof, and its application as PARP inhibitor20189,993,473Crystalline forms of tyrosine kinase inhibitors and their salts20189,982,028Recombinant human interferon-like proteins20189,738,659'Compositions of protein receptor tyrosine kinase inhibitors'20179,718,794'Crystalline forms of tyrosine kinase inhibitors and their salts'20179,388,146'Crystalline forms of tyrosine kinase inhibitors and their salts'20169,234,022'Recombinant human interferon-like proteins and method of treatment using them'20169,138,439'Methods and compositions for modulating P300/CBP activity'20159,040,508'Compositions of protein receptor tyrosine kinase inhibitors'20158,999,992'Crystalline forms of tryosine kinase inhibitors and their salts'20158,809,530'Compositions of protein receptor tyrosine kinase inhibitors'20148,758,756'Anti-human epidermal growth factor receptor antibody and uses thereof'20148,618,110'Compositions and methods for apoptosis modulators'20138,476,458'Methods and compositions for modulating P300/CBP activity'20138,425,895'Recombinant human interferon-like proteins'20137,867,482'Recombinant human interferon-like proteins'20117,868,151'Recombinant human interferon-like proteins'20117,714,146'Azulene-oxindole compounds as multiple-kinase inhibitors and useful as anticancer agents'20107,625,555'Recombinant human interferon-like proteins'20097,582,421'Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip'20096,492,122'Quantitative analysis methods on active electronic microarrays'20026,468,742'Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip'20026,379,897'Methods for gene expression monitoring on electronic microarrays'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2009Patents assigned to NANOGEN INC (4)· patent assignee history
2002–2009Based in San Diego, CA, US· patent location history
2009–2020Patents assigned to NOVAGEN HOLDING CORP (7)· patent assignee history
2009–2013Based in Vancouver, CA· patent location history
2013–2015Patents assigned to WANG LING (4)· patent assignee history
2014–2015Patents assigned to VM PHARMA LLC (3)· patent assignee history
2014–2019Based in Fremont, CA, US· patent location history
2016–2019Patents assigned to PURDUE PHARMA LP (7)· patent assignee history
2016–2020Based in Surrey, CA· patent location history
2021Based in Qingdao, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVAGEN HOLDING CORP | 7 | 2009–2020 |
| PURDUE PHARMA LP | 7 | 2016–2019 |
| NANOGEN INC | 4 | 2002–2009 |
| WANG LINGself | 4 | 2013–2015 |
| VM PHARMA LLC | 3 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fremont, California, US | 9 | 2014–2019 |
| Vancouver, CA | 4 | 2009–2013 |
| San Diego, California, US | 4 | 2002–2009 |
| Surrey, CA | 3 | 2016–2020 |
| Qingdao, CN | 2 | 2021 |